Skip to main content

Table 1 Mean body weight (±SD) and mean ADWG (±SD) per treatment group

From: Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions

PCV-2 experiment treatment groupsBody Weight (Kg)ADWG (Kg)
SD-5SD62SD83ADWG SD5-SD62ADWG SD62-SD83ADWG SD5-SD83
NV-NC3.80 ± 0.8541.95 ± 8.7563.43 ± 9.250.57 ± 0.121.02 ± 0.100.68 ± 0.10
NV-C PCV-23.81 ± 0.6838.80 ± 6.3160.61 ± 7.560.52 ± 0.091.04 ± 0.130.65 ± 0.08
VS-C PCV-23.69 ± 0,4937.25 ± 6.1656.96 ± 8,150.50 ± 0.090.94 ± 0.190.61 ± 0.09
VC-C PCV-23.65 ± 0.5237.31 ± 4.2757.61 ± 5.520.50 ± 0.060.97 ± 0.110.61 ± 0.06
Mhyo experiment treatment groupsBody Weight (Kg)ADWG (Kg)
SD-5SD62SD91ADWG SD5-SD62ADWG SD62-SD91ADWG SD5-SD91
NV-NC3.80 ± 0.8541.95 ± 8.7570,22 ± 4.660.57 ± 0.121.05 ± 0.110.69 ± 0.05
NV-C Mhyo3.77 ± 0.6539.51 ± 4.9666.09 ± 10.670.53 ± 0.070.92 ± 0.250.65 ± 0.11
VS-C Mhyo3.77 ± 0.6336.97 ± 4.3064.48 ± 5.930.50 ± 0.060.95 ± 0.110.63 ± 0.06
VC-C Mhyo3.81 ± 0.6941.06 ± 4.8670.33 ± 5.850.55 ± 0.061.01 ± 0.070.69 ± 0.06